Tradestie Institutional Equity Comparison Engine
NOVTU vs ABP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABP Overall Edge
ABP Captures Institutional Edge (1โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abpro Holdings, Inc Common Stock (ABP) driven by superior Growth & Margin while NOVTU counters with relative strength in Momentum & Technical. Fundamentally, NOVTU trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ABP at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, NOVTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NOVTU N/M vs ABP N/M Fwd P/E
Growth & Margin Winner
ABP
Op Margin N/A vs 0.0% ยท YoY N/A vs -100.0%
Momentum & Technical Winner
NOVTU
1Y -2.4% vs -98.2% ยท 52W Pos 11% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NOVTU
US Equity
NOVTU
Institutional Equity
$50.76
-1.05% 1D
Market Cap
N/A
1M Return
-9.21%
1Y Return
-2.38%
Forward P/E
N/M
Unified AI Score
42.5 / 100
HOLD
Tech 30.0
Fund 45.0
Flow 50.0
Mom 60.0
ABP
NASDAQ
Abpro Holdings, Inc Common Stock
Biological Products, (No Disgnostic Substances)
$0.52
-34.76% 1D
Market Cap
$2.2M
1M Return
-84.04%
1Y Return
-98.23%
Forward P/E
N/M
Unified AI Score
44.4 / 100
HOLD
Tech 40.0
Fund 49.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NOVTU -2.38%
ABP -98.23%
Spread: +112.61 pp (NOVTU Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NOVTU TTM Op. Margin: N/A
ABP TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NOVTU vs ABP. Trailing 12-month operating profitability (NOVTU N/A vs ABP 0.0%) and valuation multiples (NOVTU N/M vs ABP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NOVTU | ABP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $2.2M | Larger Scale | ABP |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | -100.0% | Higher Growth | ABP |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | ABP |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | ABP |
| Return on Equity (ROE) Capital Efficiency | N/A | 0.0% | Higher ROE | ABP |
| 52-Week Range Position Momentum | 11% ($48โ$77) | 0% ($1โ$32) | Stronger Trend | NOVTU |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 65% Vol | 2.33ฮฒ ยท 258% Vol | Lower Realized Risk | NOVTU |
| Unified Institutional Score Composite Signal | 42.5 / 100 (HOLD) | 44.4 / 100 (HOLD) | Higher Composite | ABP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NOVTU vs ABP Buy Guide
NOVTU
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ABP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NOVTU nor ABP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.